📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Europe close: Stocks fall back amid latest U.S. and European corporate updates

Published 2023-04-25, 01:52 p/m
© Reuters.

Sharecast - "Investors continue to trim exposure to stocks as this week's earnings barrage gets underway. [Global parcel delivery company] UPS' forecast of a weaker economy is just the kind of warning investors don't want to hear, and has likely prompted a round of selling on renewed recession fears," said IG chief market analyst Chris Beauchamp.

"With so much riding on this week’s figures, caution is still the watchword. US regional banks are under pressure again too, another sign that the rally’s foundations are weakening."

The pan-European Stoxx 600 index was down 0.40% at 467.08 with nearly all major regional bourses lower.

Spain's IBEX 35 gave back 1.23% to 9,290.30 while the French CAC 40 was off by 0.56% at 7,531.61.

Germany's Dax on the other hand eked out a gain of 0.05% to end the day at 15,872.13.

In the background, geopolitical tensions between the US and China over Taiwan continued to generate a fair bit of market commentary.

Investors were also increasingly monitoring the federal debt ceiling stand-off in the US.

In the corporate space, a slew of results and updates published across the continent.

Swiss pharma company Idorsia Ltd's (SIX:IDIA) shares retreated as it reported weaker first-quarter earnings.

Compatriot bank UBS Group AG (SIX:UBSG) (NYSE:UBS) slipped after posting a 52% net profit decline, while Spanish rival Santander (BME:SAN) was also lower despite net profit edging ahead.

Consumer goods giant Nestle (LON:0QR4) made gains after narrowly beating sales estimates but warning of a 0.5% volume decline. The company said it had hiked prices by 9.8% in the quarter.

Primark owner AB Foods (LON:ABF) slumped as it predicted flat profits this year as consumers tightened their belts amid the cost of living crisis.

Whitbread (LON:WTB) jumped as its Premier Inn hotel chain reported a sharp rise in bookings as Covid restrictions were finally lifted.

Swiss pharmaceutical firm Novartis (LON:0QLR) gained after beating sales estimates and raising its full-year earnings outlook from a “mid-to-high single digit” increase to a “high single digit to low double digit.”

Read more on Sharecast.com

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.